Cargando…

Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study

BACKGROUND: The definition of clinical target volume (CTV) in intensity modulated radiation therapy (IMRT) for nasopharyngeal carcinoma (NPC) has not been addressed. We performed this study to assess the feasibility and efficacy of using IMRT with reduced-volume CTV for the treatment of nasopharynge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fang, Luo, Ting, Jin, Tao, Zhang, Jiahui, Xiang, Zhongzheng, Yan, Ruonan, Xie, Li, Wu, Xin, Zhang, Hong, Wang, Feng, Li, Ping, Liu, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556221/ https://www.ncbi.nlm.nih.gov/pubmed/31176358 http://dx.doi.org/10.1186/s12885-019-5774-2

Ejemplares similares

The role of concurrent chemotherapy for stage II nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A systematic review and meta-analysis
por: Liu, Fang, et al.
Publicado: (2018)

The Impact of Reduced-Volume, Intensity-Modulated Radiation Therapy on Disease Control in Nasopharyngeal Carcinoma
por: Lin, Yu-Wei, et al.
Publicado: (2015)

A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis
por: Yao, Cheng-Yun, et al.
Publicado: (2018)

Advantages of intensity modulated radiotherapy in recurrent T1-2 nasopharyngeal carcinoma: a retrospective study
por: Qiu, Sufang, et al.
Publicado: (2014)

Radiation-induced temporal lobe injury after intensity modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume-outcome analysis
por: Sun, Ying, et al.
Publicado: (2013)

Radiation-induced late dysphagia after intensity-modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume effect analysis
por: Jiang, Li, et al.
Publicado: (2018)

Prognostic value of Diabetes in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy
por: Peng, Hao, et al.
Publicado: (2016)

Advantage of PET/CT in Target Delineation of MRI-negative Cervical Lymph Nodes In Intensity-Modulated Radiation Therapy Planning for Nasopharyngeal Carcinoma
por: Shen, Guanzhu, et al.
Publicado: (2017)

Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis
por: Sun, Wen-zhao, et al.
Publicado: (2018)

Correction to: Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis
por: Sun, Wen-zhao, et al.
Publicado: (2018)

Radiation caries in nasopharyngeal carcinoma patients after intensity-modulated radiation therapy: A cross-sectional study
por: Liang, Xue, et al.
Publicado: (2016)

Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy
por: Zheng, YingJie, et al.
Publicado: (2015)

Application of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma
por: Yan, Hao, et al.
Publicado: (2017)

Skin Sparing in Intensity-Modulated Radiation Therapy of Nasopharyngeal Carcinoma
por: Baba, Misba Hamid, et al.
Publicado: (2022)

Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Liang, Shao-Bo, et al.
Publicado: (2017)

Dosimetric Comparison of Helical Tomotherapy, Volume-Modulated Arc Therapy, and Fixed-Field Intensity-Modulated Radiation Therapy in Locally Advanced Nasopharyngeal Carcinoma
por: Lu, Shan, et al.
Publicado: (2021)

Predictors of Mastoiditis after Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma: A Dose-Volume Analysis
por: Yao, Ji-Jin, et al.
Publicado: (2016)

Target volume and position variations during intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
por: Tan, Wenyong, et al.
Publicado: (2013)

Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era
por: Yang, Xing‐Li, et al.
Publicado: (2020)

Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategies
por: Xu, Yi, et al.
Publicado: (2022)

Prognostic Significance of Tumor Volume in Locally Recurrent Nasopharyngeal Carcinoma Treated with Salvage Intensity-Modulated Radiotherapy
por: Xiao, WeiWei, et al.
Publicado: (2015)

Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy
por: Su, Sheng-Fa, et al.
Publicado: (2011)

Dosimetric advantages of intensity modulated radiation therapy in locally advanced lung cancer
por: Boyle, John, et al.
Publicado: (2017)

Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma
por: Yao, Ji-Jin, et al.
Publicado: (2015)

A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy (IMRT)
por: Kang, Min, et al.
Publicado: (2017)

Effect of relevant factors on radiation‐induced nasopharyngeal ulcer in patients with primary nasopharyngeal carcinoma treated with intensity‐modulated radiation therapy
por: Fei, Zhaodong, et al.
Publicado: (2020)

A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma
por: Li, H. M., et al.
Publicado: (2016)

Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma
por: Li, Pei-Jing, et al.
Publicado: (2015)

Induction chemotherapy reduces target volume drift in patients with locoregionally advanced nasopharyngeal carcinoma undergoing adaptive intensity-modulated radiotherapy: a retrospective cohort study
por: Yan, Danfang, et al.
Publicado: (2023)

Thyroid dose‐volume thresholds for the risk of radiation‐related hypothyroidism in nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy—A single‐institution study
por: Huang, Cheng‐Long, et al.
Publicado: (2019)

Prognostic value of hypertension in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
por: Yin, Wen-Jing, et al.
Publicado: (2021)

Analysis of Clinical Target Volume Delineation in Local-regional Failure of Nasopharyngeal Carcinoma after Intensity-modulated Radiotherapy
por: Yang, Xiaojing, et al.
Publicado: (2020)

A feedback constraint optimization method for intensity-modulated radiation therapy of nasopharyngeal carcinoma
por: LI, YONGWU, et al.
Publicado: (2015)

Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
por: Feng, Mei, et al.
Publicado: (2013)

Predicting Nomogram for Severe Oral Mucositis in Patients with Nasopharyngeal Carcinoma during Intensity-Modulated Radiation Therapy: A Retrospective Cohort Study
por: Liu, Zhibing, et al.
Publicado: (2022)

Intensity-modulated carbon-ion radiation therapy versus intensity-modulated photon-based radiation therapy in locally recurrent nasopharyngeal carcinoma: a dosimetric comparison
por: Wang, Lei, et al.
Publicado: (2019)

Comparative Study of Auto Plan and Manual Plan for Nasopharyngeal Carcinoma Intensity-Modulated Radiation Therapy
por: Xin, Xin, et al.
Publicado: (2020)

Prognostic Impact of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Treated using Intensity-Modulated Radiation Therapy
por: Peng, Hao, et al.
Publicado: (2016)

The Impact of Clinical Stage on Radiation Doses to Organs at Risk Following Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma: A Prospective Analysis
por: Xu, Lin, et al.
Publicado: (2016)

Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3–4 nasopharyngeal carcinoma
por: Xue, Fen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0fcsunfolstnlrigrg36b3bv0t